Clinical Trials

Inclusion Criteria:

• Diagnosed with episodic migraine at least 6 months before study
• At least 3 consecutive months of stable migraine headaches before study
• At least 4-14 headache days per month, of which 4-14 may be migraines
• Must not have failed on more than 2 classes of migraine preventatives

Exclusion Criteria:

• Previous use of the experimental device
• Pregnant
• Using more than 1 concurrent migraine preventive
• History of cardiovascular disease
• Work night shifts
• Diagnosed with vestibular migraine
• Menstrual migraines exclusively
• Diagnosed with post-traumatic migraine
• Have a history of unstable mood or anxiety disorder
• Use a hearing aid
• Have a cochlear implant
• Have chronic tinnitus
• Have temporomandibular joint disease
• Diagnosed with traumatic brain injury
• Diagnosed with neurological disease other than headaches
• Diagnosed vestibular and/or balance dysfunction
• History of abusing alcohol or other drugs
• Are experiencing medication overuse headaches
• Have had eye surgery in the previous 3 months
• Have had ear surgery in the previous 6 months
• Have active ear infections or a perforated tympanic membrane
• Have participated in another clinical trial in the last 30 days
• Are currently participating in another clinical trial
• Using Botulinum toxin-based treatments for migraines or cosmetic reasons
• Taking anti-emetics more than 2 times per week (consistently)